|
Qi Lab Publication 2008-present
Ling Qi's Publication from 2000-2007 - Qi, L.*, Heredia, J.*, Altarejos, J.Y., Screaton, R., Goebel, N., Niessen, S., MacLeod, I.X., Liew, C.W., Kulkarni, R., Bain, J., Nelson, M., Evans, R.M., Yates, J., and Montminy, M. 2006. TRB3 links the E3 ubiquitin ligase COP1 to lipid metabolism. Science. 312: 1763-6 (*, contribute equally) [PDF]
- Koo, S.H.*, Flechner, L.*, Qi, L., Zhang, X., Screaton, R.A., Jeffries, S., Hedrick, S., Xu, W., Boussouar, F., Brindle, P., Takemori, H., and Montminy, M. 2005. The CREB coactivator TORC2 is a key regulator of fasting glucose metabolism. Nature. 437: 1109-15 (*, contribute equally) [PDF]
- Qi, L., Strong, M.A., Karim, B.O., Huso, D.L., and Greider, C.W. 2005. Telomere fusion to chromosome breaks reduces oncogenic translocations and tumor formation. Nature Cell Biology. 7: 706-11. [PDF]
- Qi, L., Strong, M.A., Karim, B.O., Armanios, M., Huso, D.L., and Greider, C.W. 2003. Short telomeres and ataxia-telangiectasia mutated deficiency cooperatively increase telomere dysfunction and suppress tumorigenesis. Cancer Research. 63: 8188-96. [PDF]
- Dolan, B.P., Phelan, T.P., Ilkovitch, D., Qi, L., Wade, W.F., Laufer, T.M., and Ostrand-Rosenberg, S. 2004. Invariant chain and the MHC class II cytoplasmic domains regulate localization of MHC class II molecules to lipid rafts in tumor cell-based vaccines. Journal of Immunology. 172: 907-14. [PDF]
- Qi, L. and Ostrand-Rosenberg, S. 2001. H2-O inhibits presentation of bacterial superantigens, but not endogenous self-antigens. Journal of Immunology. 167: 1371-8. [PDF]
- Qi, L. and Ostrand-Rosenberg, S. 2000. MHC Class II presentation of endogenous tumor antigen by cellular vaccines depends on the endocytic pathway but not H2-M. Traffic. 1: 152–160. [PDF]
- Qi, L., Rojas, J., Ostrand-Rosenberg, S. 2000. Tumor cells present MHC class II-restricted nuclear and mitochondrial antigens and are the predominant antigen presenting cells in vivo. Journal of Immunology. 165: 5451-5461. [PDF]
|
